| German pain, American gain | 25-MAY-09 |
|
| While headaches on account of Betapharm could ease, Dr Reddy’s is banking on its American operations to boost profitability. |
|
|
|
| Dr Reddy's: Betapharm blues | 20-MAY-09 |
|
| Betapharm continues to be a bit of headache for Dr Reddy’s Laboratories, which has been forced to write off a notional Rs 1,400 crore on account of its German subsidiary. A sum of Rs 316 crore has been written off towards intangible assets and another Rs 1,086 crore for goodwill. That left the Hyderabad-based drug major reeling with a loss of Rs 520-crore last year, though adjusted for these losses, net profits were up a robust 89 per cent to Rs 850 crore. |
|
|
|
| Dr Reddy's Labs back in the black | 21-JAN-09 |
|
| Dr Reddy’s Laboratories, India’s biggest drug maker by sales, said it turned to profit in the third-quarter, helped by higher sales of an authorised generic drug in the US, even as it set aside money for foreign exchange losses. |
|
|
|
| Betapharm boost | 15-DEC-08 |
|
| Its presence in key markets of the US, Germany and CIS is helping Dr Reddy’s to ramp up revenues and profits. |
|
|
|
| Dr Reddy's: Betting on Betapharm | 07-NOV-08 |
|
| Dr Reddy’s Laboratories (DRL) believes it can grow revenues by 25 per cent in the current year from Rs 5, 006 crore in FY08. Some of that will come from a weaker rupee but adverse currency |
|
|
|
|
|
|
| Pharma firms shift foreign units output home | 28-MAY-07 |
|
| After making big-ticket acquisitions abroad, leading Indian pharmaceutical companies like Dr Reddys Laboratories, Ranbaxy Laboratories, and Aurobindo Pharma are rapidly shifting production to their |
|
|
|
|
|
|
| Dr Reddy's: betapharm push | 10-MAR-06 |
|
| CLSA Asia Pacific Markets recommends a buy on Dr Reddys. The report is upgrading its forecasts for the company for 2006-07 by 33 per cent. This will reflect the companys recent acquisition of |
|
|
|
|
|
|
| Dr Reddy's to buy betapharm | 17-FEB-06 |
|
Largest overseas buy by Indian firm at Rs 2,688 cr.
Hyderabad-based Dr Reddys Laboratories today announced it had entered into an agreement with Europes leading private equity house 3i |
|
|
|
|
|
|
|
|
|
| Ranbaxy in race for Betapharm | 08-FEB-06 |
|
| The countrys largest pharmaceutical company, Ranbaxy Laboratories Ltd, is believed to have put in a bid of 500 million (approximately Rs 2,800 crore) for Germanys fourth largest generic company, |
|
|
|
|
|
|
Content Guide
